T cell immunotherapy for cardiac fibrosis: mRNA starts the CAR. Cell Stem Cell. 2022;29(3):352-354..
Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn's disease. Gut. 2022.
Tailoring Cu-loaded electrospun membranes with antibacterial ability for guided bone regeneration. Biomater Adv. 2022;139:212976..
[Take-home messages from the COPD 2021 biennial of the French Society of Respiratory Diseases. Understanding to so as to better innovate]. Rev Mal Respir. 2022.
Taking the guesswork out of journal submission with Community Review. Cell Stem Cell. 2022;29(5):663-666..
Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates. NPJ Regen Med. 2022;7(1):19..
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment. J Transl Med. 2022;20(1):320.
Targeted DamID in reveals a direct role for LIN-22 and NHR-25 in antagonizing the epidermal stem cell fate. Sci Adv. 2022;8(5):eabk3141..
Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer. Toxicol Appl Pharmacol. 2022:116036..
Targeted liposomal doxorubicin/ceramides combinations: the importance to assess the nature of drug interaction beyond bulk tumor cells. Eur J Pharm Biopharm. 2022..
Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2022.
Targeted mitochondrial delivery: A therapeutic new era for disease treatment. J Control Release. 2022..
Targeted therapy and drug resistance in thyroid cancer. Eur J Med Chem. 2022;238:114500..
Targeting AML at the intersection of epigenetics and signaling. Sci Signal. 2022;15(730):eabo0059..
Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies. JCO Precis Oncol. 2022;6:e2200208..
Targeting bacterial biofilms using vancomycin and multivalent cell-penetrating peptide labeled quantum dots. J Biomed Mater Res B Appl Biomater. 2022..
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. Eur J Med Chem. 2022;237:114346..
Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors. Pharmacol Res. 2022:106425..
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate. Cancer Sci. 2022.
Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles. Colloids Surf B Biointerfaces. 2022;217:112612..
Targeting HNRNPM inhibits cancer stemness and enhances antitumor immunity in Wnt-activated hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol. 2022.
Targeting micro-environmental pathways by PROTACs as a therapeutic strategy. Semin Cancer Biol. 2022..
Targeting miR-30d reverses pathological cardiac hypertrophy. EBioMedicine. 2022;81:104108.
Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling. Bioorg Med Chem. 2022;70:116920..
Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy. Semin Cancer Biol. 2022..